Ian G Cowell

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Open biology

FEBS open bio

Molecular pharmacology

FEBS letters

Newcastle University

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Newcastle University Mar 01 2003

United Kingdom

Staff Scientist :: Newcastle University Biosciences Institute

Education History

University of London

United Kingdom

PHD :: Biochemistry

University of London

United Kingdom

BSC :: Biochemistry

Publications

Ian G Cowell, Caroline A Austin
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide. FEBS open bio 14 (6) (2024)
Ian G Cowell, Caroline A Austin
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide. FEBS open bio (2024)
Ian G Cowell, Caroline A Austin
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide. FEBS open bio 14 (6) (2024)
Ian G Cowell, Caroline A Austin
Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide. FEBS open bio 14 (6) (2024)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, John W Casement, Caroline A Austin
To Break or Not to Break: The Role of TOP2B in Transcription. International journal of molecular sciences 24 (19) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Ian G Cowell, Caroline A Austin
DNA fragility at the KMT2A / MLL locus: insights from old and new technologies. Open biology 13 (1) (2023)
Katja E Menger, James Chapman, Héctor Díaz-Maldonado, Mushtaq M Khazeem, Dasha Deen, Direnis Erdinc, John W Casement, Valeria Di Leo, Angela Pyle, Alejandro Rodríguez-Luis, Ian G Cowell, Maria Falkenberg, Caroline A Austin, Thomas J Nicholls
Two type I topoisomerases maintain DNA topology in human mitochondria. Nucleic acids research 50 (19) (2022)
Mushtaq Mufleh Khazeem, John W Casement, George Schlossmacher, Niall S Kenneth, Nielda K Sumbung, Janice Yuen Tung Chan, Jade F McGow, Ian G Cowell, Caroline A Austin
TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma Cells. Molecular neurobiology 59 (10) (2022)
Caroline A Austin, Ian G Cowell, Mushtaq Mufleh Khazeem, Dawn Lok, Huei Teng Ng
TOP2B's contributions to transcription. Biochemical Society transactions (2021)
Rebecca L Swan, Luke L K Poh, Ian G Cowell, Caroline A Austin
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes. Molecular pharmacology 98 (3) (2020)
Mushtaq Mufleh Khazeem, Ian G Cowell, Lauren F Harkin, John W Casement, Caroline A Austin
Transcription of carbonyl reductase 1 is regulated by DNA topoisomerase II beta. FEBS letters 594 (20) (2020)
Mandeep Atwal, Rebecca L Swan, Chloe Rowe, Ka C Lee, David C Lee, Lyle Armstrong, Ian G Cowell, Caroline A Austin
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations. Molecular pharmacology 96 (4) (2019)
Ian G Cowell, Elise M Ling, Rebecca L Swan, Matilda L W Brooks, Caroline A Austin
The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison. Molecular pharmacology 96 (5) (2019)

Ian G Cowell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ian G Cowell